CHAN BROAD SPEC ORAL SUSPENSION
Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Summary of Product characteristics
(SPC)
10-05-2024
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
RAFOXANIDE, LEVAMISOLE HYDROCHLORIDE
Available from:
Chanelle Pharmaceuticals Manufacturing Limited
ATC code:
QP52AE01
INN (International Name):
RAFOXANIDE, LEVAMISOLE HYDROCHLORIDE
Dosage:
%v/v
Pharmaceutical form:
Oral Suspension
Prescription type:
LM-Licensed Merchant
Therapeutic group:
Bovine, Ovine
Therapeutic area:
Levamisole QP52AG05 Rafoxanide
Therapeutic indications:
Endoparasiticide
Authorization status:
Authorised
Authorization date:
1989-10-01
Summary of Product characteristics
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Chan Broad Spec Oral Suspension
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
For a full list of excipients see section 6.1.
3 PHARMACEUTICAL FORM
Oral suspension.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cattle, sheep.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Chan Broad Spec is effective in the treatment and control of roundworm, lungworm and fluke infections in cattle and
sheep. It is highly effective against mature and developing immature stages of levamisole-susceptible major nematode
species: _Haemonchus _spp, _Ostertagia _spp (except inhibited _Ostertagia _larvae in cattle), _Nematodirus _spp,
_Trichostrongylus _spp, _Cooperia _spp, _Oesophagostomum _spp, _Chabertia _spp and _Bunostomum _spp and lungworms causing
hoose (husk) in cattle and sheep. Chan Broad Spec is highly effective against mature fluke in cattle and sheep and 83%
effective against 4-week old immature fluke in sheep. Chan Broad Spec is also effective against _Oestrus ovis _in sheep.
4.3 CONTRAINDICATIONS
Do not use in animals with known hypersensitivity to the active ingredients.
Do not use in animals less than 6 months of age.
Each ml contains:
Active Substances
Rafoxanide
22.5 mg
Levamisole Hydrochloride 15
mg
Excipients
Patent Blue V (E131)
0.005 mg
Sodium metabisulphite
1.0
mg
IRISH MEDICINES BOARD
________________________________________________________________________________________________________________________
_Date Printed 23/01/2014_
_CRN 7016824_
_page number: 1_
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
Care should be taken to avoid the following practices because they increase the risk of development of resistance and could
ultimately result in ineffective therapy:
•
Too frequent and repeated use of anthelmintics from the same cl
Read the complete document
